Veterinary Medicinal Product Residues (VMPR) National Control Plans
Regulation EU 2017/625 requires that EU Member States, Iceland, Norway, and the United Kingdom (Northern Ireland), perform official controls on the use of pharmacologically active substances authorised as veterinary medicinal products, or as feed additives, and of prohibited or unauthorised pharmacologically active substances and residues thereof. This is undertaken on the basis of a multiannual national control plan (‘MANCP’). EFSA delivers an annual report on the results of these official controls.
Additionally, regulations EU 2022/1644 and EU 2022/1646 lay down the rules and content of the MANCP as regards these substances and residues, applicable to the national control plans from 2023 onward.
Deadlines for 2026 VMPR National Control Plans (NCP) data reporting and validation
1 March 2026
Data collection framework and MicroStrategy open for data and text information transmission by Member States (MS)
31 March 2026
Deadline for data validation and acceptance of VMPR NCP data and text information collection by MSs.
Validation Dashboards (VD) will be available in MicroStrategy; any change in data during the data reporting and correction periods will be displayed automatically in the VD the day following a dataset submission.
VMPR NCP supporting material
- The Guidance of the VMPR NCP DC
- The Zenodo page with the tools for reporting the VMPR NCP data
Catalogues in MS Excel format
Major release of DCF Catalogues is planned every year in January. Thus, the updated version of “DCF_catalogues” file in Zenodo will be available by the end of January.
The EFSA catalogues for data reporting are available in Excel format for ease of use and reference. The catalogues are published on the EFSA Knowledge Junction (Zenodo) (an open access research data repository).